<DOC>
	<DOCNO>NCT00630448</DOCNO>
	<brief_summary>Von Willebrand disease inherit bleed disorder impact blood 's ability clot properly . Von Willebrand disease cause lack work substance blood know Von Willebrand factor . Current therapy Von Willebrand disease include desmopressin acetate ( DDAVP ) /or VWF/FVIII concentrate . Patients severe Von Willebrand disease face lifetime weekly treatment mount medical bill . Gene therapy could help patient improve quality life provide miss factor necessary blood 's ability clot properly . The gene transfer option study include naked DNA , viral gene transfer vector encode Von Willebrand factor transgene , ex vivo cell therapy . The latter involve transplantation patient 's cell modify correct copy defective gene . Human blood outgrowth endothelial cell ( BOEC ) display property need successful ex vivo cell therapy . We plan obtain blood sample normal research subject patient Von Willebrand Disease order isolate blood outgrowth endothelial cell ( BOEC ) peripheral blood , develop ex vivo gene therapy Von Willebrand Disease .</brief_summary>
	<brief_title>Collection Blood Normal Subjects Subjects With Von Willebrand Disease ( VWD )</brief_title>
	<detailed_description>Aim : The purpose protocol obtain blood sample normal research subject patient Von Willebrand disease order isolate blood outgrowth endothelial cell ( BOEC ) peripheral blood , develop ex vivo gene transfer Von Willebrand disease . Experimental procedure . This protocol design gather approximately 90 ml ( 6 tablespoon ) blood normal individual without Von Willebrand disease individual know Von Willebrand disease . A total 20 normal individual 20 Von Willebrand disease patient enrol study . Studies perform blood sample : Each blood draw require 10 large blue/black cap ( Na Citrate ) vacutainer ( 16x125mm , BD # 362761 , Cell Preparation Tubes ( CPT ) fill volunteer . All blood use cell processing . In initial proof-of-concept experiment , BOEC line establish peripheral blood normal individual research subject Von Willebrand disease . Following culture phenotypic characterization , transduce lentivirus gene transfer vector express reporter gene wild-type Von Willebrand factor . After demonstrate successful transduction , next step write animal protocol introduce modify cell immunocompromised mouse monitor mouse stable implantation .</detailed_description>
	<mesh_term>Von Willebrand Diseases</mesh_term>
	<criteria>1 . Normal subject : study individual take enrol WeillIRB protocol # 0005004439 entitle `` Evaluation Lungs Normal ( Smokers , Exsmokers , Nonsmokers ) Individuals Segmental Bronchopulmonary Lung Lavage , Bronchial Brushing , Bronchial Wall Biopsy '' 2 . Subjects von Willebrand Disease definitive diagnosis VWD patient 's physician subject able provide inform consent male females 1870 year age 1 . Normal individual individual history bleeding disorder individual anemia ( defined female Hgb concentration le 12 male HgB concentration le 12.5 ) 2 . Subjects VWD females pregnant accept study individual anemia ( defined female Hgb concentration le 12 male Hgb concentration le 12.5 )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>